Final STAT@ASH agenda announced — Last call to join us next week

UPCOMING EVENT

Next week, STAT reporters will be on the ground in Orlando for the 67th ASH Annual Meeting — and we invite you to join us for STAT@ASH: Standing on Medicine's Threshold.

This intimate Friday evening event is a chance to connect with peers and hear live interviews with leaders from Johnson & Johnson, Bristol Myers Squibb, Kite Pharma Inc., and more. The full agenda is now live.

Featured speakers:

Bethany Samuelson Bannow, M.D., MCR, incoming editor-in-chief, ASH Clinical News; director of Classical Hematology, Cleveland Clinic; co-chair, ASH's Women in Hematology Committee
Yusri Elsayed, M.D., Ph.D., senior vice president, global oncology therapeutic area head, Johnson & Johnson
Lore Gruenbaum, Ph.D., chief scientific officer and senior vice president of research, Blood Cancer United
Lynelle B. Hoch, president, cell therapy organization, Bristol Myers Squibb
Cindy Perettie, executive vice president, Kite Pharma Inc.

Conversations will explore new discoveries in blood science, what's next for CAR-T, and where hematology is headed — including the field's evolving research priorities and why investing in blood science is vital for the entire medical ecosystem.

We hope you'll join us. RSVP now for our Friday, Dec. 5 event.

RSVP HERE